A novel adamantyl benzylbenzamide derivative, AP736, suppresses melanogenesis through the inhibition of cAMP-PKA-CREB-activated microphthalmia-associated transcription factor and tyrosinase expression

Topical Hypopigmenting Agents for Pigmentary Disorders and Their Mechanisms of Action

(2012) Hyojin Kim et al.   Annals of Dermatology

Adamantyl N-benzylbenzamide: New series of depigmentation agents with tyrosinase inhibitory activity

(2012) Heung Soo Baek et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Suppression of melanogenesis by a newly synthesized compound, MHY966 via the nitric oxide/protein kinase G signaling pathway in murine skin

(2012) Yeon Ja Choi et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Liver X Receptor Activation Inhibits Melanogenesis through the Acceleration of ERK-Mediated MITF Degradation

(2012) Chang Seok Lee et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Aromatic-turmerone inhibits α-MSH and IBMX-induced melanogenesis by inactivating CREB and MITF signaling pathways

(2011) Sun Young Park et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

5,7-Dimethoxyflavone induces melanogenesis in B16F10 melanoma cells through cAMP-dependent signalling

(2011) Young-Gyu Kang et al.   EXPERIMENTAL DERMATOLOGY

Depigmenting action of platycodin D depends on the cAMP/Rho-dependent signalling pathway

(2011) Eunsun Jung et al.   EXPERIMENTAL DERMATOLOGY

Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors

(2011) Ping Wan et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

“Transcription physiology” of pigment formation in melanocytes: central role of MITF

(2010) Jiri Vachtenheim et al.   EXPERIMENTAL DERMATOLOGY

Physiological factors that regulate skin pigmentation

(2009) Yuji Yamaguchi et al.   BIOFACTORS